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Objectives. Aprimarymethodological weakness of the single-case experimental design
(SCED) outcome studies conducted of the treatment of personality disorder with
cognitive analytic therapy (CAT) is that they have failed to employ a withdrawal phase or
cross-over design and so are deemed quasi-experimental. This study sought to implement
a withdrawal design, in order to improve the internal validity of the study tomake it a true
SCED, and also in order to enable the patient to explore abandonment dynamics.
Design. The study employed an A1/B1/A2/B2 with extended follow-up SCED with a
female patient treated with CAT meeting diagnostic criteria for borderline personality
disorder (BPD). Following the 6-week baseline period ‘A1’, treatment occurred in two
phases (21 sessions ‘B1’ and 24 sessions ‘B2’) sandwiching a 12-week treatment
withdrawal phase (‘A2’) and a 24-week structured follow-up phase. Seven idiographic daily
measures were collected that created a N = 698 day timeline. Nomothetic outcome
measures were collected at baseline and at the end of each phase of the study, and the
Session Impact Scale was completed after each treatment session.
Results. There was a significant increase in the task focus of treatment sessions.
Ideographically, CAT was an effective treatment for improving the participant’s self-to-
self relationship, as their self-hate reduced and their sense-of-self increased. There was a
broad pattern of deterioration during the second treatment phase (B2) and follow-up
phase across the ideographic measures, and CAT was ineffective for BPD ideographic
emotional or self-to-other measures. Reliable change occurred on the primary BPD
nomothetic outcome measure from baseline to end of first treatment phase.
Conclusions. The study suggests that theCAT interventionwas partially successful and
that it is possible to integrate good research practice with clinical innovation. The
methodological strengths and limitations of the design and the clinical implications of the
results are discussed.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and
reproduction in any medium, provided the original work is properly cited.
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Practitioner points
 Cognitive analytic therapy was partially effective in the treatment of BPD in a case that had been
unresponsive to other psychological interventions.
 Therapists need to complete lengthy and structured follow-up to capture any emerging relapse.
 Therapists need to discuss the patient’s thoughts and feelings about termination regularly in a
relationally informed manner.
The DSM-5 (APA, 2013) dimensional trait model of personality disorder (PD) consists of
five broad domains of negative affectivity, detachment, psychoticism, antagonism, and
disinhibition. As noted, ‘these five broad domains are maladaptive variants of the five
domains of the extensively validated and replicated personality model known as the ‘Big
Five,’ or the Five Factor Model of personality’ (APA, 2013, p. 773). Borderline personality
disorder (BPD) can therefore be characterized using the five-factor model in terms of the
personality features of persistent dysregulated rage, despondency, self-disturbance,
emotional dysregulation, behavioural dysregulation, dissociation, and impulsivity (Widi-
ger, 2015). BPD patients can be a challenge to treat psychotherapeutically as chronically
dysfunctional interpersonal relationships (Widiger, 2015) can get repeated within and so
negatively impact on the therapeutic dynamics, therefore creating pressure on boundary
management in the patient–therapist relationship (Fonagy & Bateman, 2006; Skodol,
et al., 2002). Such relational difficulties mean that patients with PD can often face the
double stigma of having a complex and enduring mental health problem and also being
part of often difficult, unhelpful and potentially iatrogenic interactions with services
(Black et al., 2011). BPD patients are therefore high consumers of resources across in-
patient, community team, and primary care settings, but where staff can experience BPD
patients as ‘hard-to-help’ or ‘difficult’ due to their often provocative, confusing and
alienating interpersonal behaviours (Kerr, 1999).
Clearly, BPD is both a contested and stigmatized psychiatric diagnosis, particularly
when used with younger people (Koehne, Hamilton, Sands, & Humphreys, 2013), and so
BPD generates more research and associated debate than all the other personality
disorders (Boschen & Warner, 2009). The BPD diagnosis is frequently critiqued as a
construction which pathologizes any deviation from societal norms (Shaw & Proctor,
2005), and this is particularly apparent with female patients (Wirth-Cauchon, 2001). BPD
and bipolar disorder (types I and II) are also frequently confused due to the apparent
mood-related symptomatic overlap, with such misdiagnosis then preventing any
potentially effective intervention being delivered (Paris & Black, 2015). The cognitive
analytic approach to BPD neither dismisses nor supports the diagnostic debate, but rather
presents a structural model of BPD that focuses on the presence of multiple self-states
(Pollock, Broadbent, Clarke, Dorrian, & Ryle, 2001). These self-states are established as a
means of surviving childhood trauma and are maintained through ongoing dissociation,
with three levels of increasing damage to reflective capacity possible (Ryle, 1997). The
self-states approach enables the CAT therapist to name, map and work with separate
states in an effort to enable integration, rather than being confused or over-whelmed by
themultiplicity of apparent problems (and associatedmeans of relating) the patientmight
present with both across and within sessions (Ryle & Kellett, 2018).
Cognitive analytic therapy (CAT) as a brief, integrative and relational psychotherapy
(Ryle&Kellett, 2018) appears to be an acceptable, safe and effective intervention for BPD,
as evidenced by the (admittedly small) number of cohort and randomized controlled trials
completed thus far (Chanen et al., 2008; Kellett, Bennett, Ryle & Thake, 2013; Ryle &
Golynkina, 2000; Wildgoose, Clarke & Waller, 2001). These studies use the mean group
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response to analyse change, which unfortunately obscures the responsivity (or not) of
individual patients (Heneghan,Goldacre,&Mahtani, 2017). Therefore, as a supplement to
evidence generated by cohort and controlled studies, single-case experimental designs
(SCED) are a potentially useful and cost-effective method of determining specific
mechanisms of change in psychotherapies for BPD (Rizvi & Nock, 2008). SCEDs focus on
individual patients aiming to predict and influence therapeutic change via the defining
features of (1) repeated and intensive sampling of ideographic measures starting with a
baseline, (2) manipulation of one or more independent variables whilst controlling for
sources of bias, and (3) demonstration of stability within and across levels of imposed
independent variables (Berghoff & Forsyth, 2015). The more controlled the SCED
methodology, the more likely the identification of important facilitators of change and/or
insights into the role played by clinically relevant variables (Barlow, Nock & Herson,
2009).
Studies have investigated BPD outcomes via various SCED methods for behavioural
therapy (Bloxham, Long, Alderman,&Hollin, 1993), cognitive therapy (Davidson&Tyrer,
1996), schema therapy (Nordahl & Nysæter, 2005), and dialectical behaviour therapy
(Rizvi & Linehan, 2005). There have however been no previous SCED studies of CAT for
BPD. There is however a CAT SCED evidence base with other personality disorders:
paranoid personality disorder (PPD; Kellett & Hardy, 2014), histrionic personality
disorder (HPD; Kellett, 2007), and dependent personality disorder (Kellett & Lees, 2019).
It is worth noting that all of these studies used the basic bi-phasic A/B design and therefore
would be categorized as only quasi-experimental (Shadish & Sullivan, 2011) – despite the
lengthy additional follow-up phase in each of these studies. An A/B case series would be
seen as experimental when participants are randomized to a staggered treatment start in a
multiple baseline design (Christ, 2007). In an N = 1 study, in order to evaluate outcomes
with greater confidence therefore requires some form of experimental manipulation,
such as a withdrawal of treatment or a treatment comparison (i.e., cross-over) phase
(Barlow, Nock & Herson, 2009).
The present study therefore used a true SCED design single case that involved a
treatment withdrawal phase, an A/B/A/B design (Hersen, 1990). An A/B/A/B design
measures a baseline phase in ideographic measures (A1 in the current study), a treatment
phase (the B1 in the current study), the withdrawal of treatment (A2 in the current study),
and the reintroductionof treatment (theB2 in the current study). Effective interventions in
such designs are recorded when the removal of treatment (A2) means that outcomes
return to baseline levels (A1), and this is most readily implemented with purely
behavioural interventions. It is acknowledged that because the current study was
evaluating a psychotherapy, where the aim/hope is to facilitate learning in the patient,
then the removal of treatment is not as ‘clean’ as during purely behavioural interventions.
Therefore, any change that occurs during the first treatment phase (B1) may be retained
across the treatment removal phase, due to the patient internalizing the change methods
in the first treatment phase. It is recognized that there is also a marked ethical dilemma
when conducting withdrawal designs, as the design is beneficial from a scientific point of
view, but potentially harmful to the patient, particularly when previously effective
treatments are removed (Hersen, 1990). Treatmentwithdrawal has the potential for cuing
deterioration; however, such a design is essential in the reliable attribution of progress to
treatment effects (Hersen, 1990).
There have been previous calls for the employment of withdrawal designs in the CAT
SCED literature (Kellett&Lees, 2019). Clinically, thewithdrawal designwas also indicated
due to a fear of abandonment or rejection sensitivity being key feature of BPD
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(Palihawadana, Broadbear&Rao, 2019). Rejection sensitivity is defined as ‘the disposition
to anxiously expect, readily perceive and intensely react to rejection’ (Downey, Mougios,
Ayduk, London, & Shoda, 2004, p. 668), and in the CATmodel, this would be summarized
as an abandoning–abandoned reciprocal role (Ryle & Kerr, 2003). Patients with BPD
often struggle with such abandonment issues during and at the end of therapy, and CAT
tries to anticipate this in the narrative reformulation and also the goodbye letters (which
are distinctive features of the CAT approach; Ryle & Kellett, 2018) and in the analysis of
abandoning–abandoned reciprocal role dynamicswithin the therapeutic relationship and
in relationships with others, such as staff involved in the care of the patient (Ryle, Kellett,
Hepple, & Calvert, 2014). Therefore, the opportunity of an A/B/A/B design was that the
treatment withdrawal (i.e., A2) would allow the participant to practise tolerating a period
without therapy, test out abandonment fears, express feelings about the ending, enable
the analysis of associated enactments in the therapeutic relationship, and also give an
opportunity to put into place the ‘exits’ learnt during the first phase of treatment.
Palihawadana et al. (2019) have particularly called for studies investigating the role of
abandonment fears during the treatment of BPD. The hypotheses for the current study
were as follows: (1) there would be significant improvements in idiographic BPD
measures during active treatment phases compared to baseline and withdrawal, (2)
changes in the ideographic BPD measures would be sustained over the follow-up period,
and (3) therewould be a clinical and reliably significant change on theprimarynomothetic
BPD outcome measure.
Method
Design
The reporting of this study is based on the single-case reporting guidelines (SCRIBE; Tate
et al., 2016), and ethical approval for the studywas granted (ref: 032506). The participant
provided consent for the study to be conducted and reported, and this is consistent with
guidance on the ethics of reporting single cases (Cooper, Turpin, Bucks, & Kent, 2005).
The study uses an A/B/A/B design, with an extended follow-up (Hersen, 1990) and
contained a range of ideographic and nomothetic measures. The study employed a
structured 6-month follow-up period, as that is part of the treatment model of CAT with
BPD (Ryle & Kellett, 2018). Seven idiographic measures were completed on a daily basis
throughout all phases of the study. The baseline phase (A1) spanned 6 weeks and three
sessions. Treatment phase (B1) lasted for 24 weeks and contained 19 treatment sessions.
The treatment withdrawal phase (A2) spanned 16 weeks. The second treatment phase
(B2) spanned 28 weeks and consisted of 24 sessions. The follow-up phase was 25 weeks.
The study therefore constituted a time series of N = 698 days containing 5 distinct
phases. Nomothetic outcomemeasures were completed at start of the baseline phase and
then at the end of each phase of the study. The Session Impact Scale (Elliott & Wexler,
1994) was administered after each treatment session (i.e., 48 sessions). The SIS scores
were categorized as baseline (sessions 1-3 during A1), 4-24 (i.e., treatment sessions during
B1), and 25–48 (i.e., treatment sessions during B2).
The patient
The patient was 46-year-old single woman, who lived alone in a rented flat and was
unemployed and claiming associated welfare benefits. The patient had been previously
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assessed by a psychiatrist, and the diagnosis was BPDwith comorbid recurrent depressive
disorder. Before the start of the present study, the patient was interviewed with the
Structured Clinical Interview for DSM-IV (SCID-I/SCID-II; First, Gibbon, Spitzer, Williams,
& Benjamin, 1997). This semi-structured clinical interview yields a diagnosis consistent
withDSM-IV/DSM-IV-TR (American Psychiatric Association, 2000) diagnostic criteria, and
the patient met diagnostic criteria for BPD. The patient had been in contact with mental
health services for 18-years prior to the present study. Throughout contact with services,
the patient complained of persistent lowmood, poor sleep, hopelessness, isolation, active
suicidal thoughts, problems with impulse control, hearing a critical female voice,
compulsive exercise, substance misuse, self-harm, and interpersonal intolerance. The
patient was consistently described as very difficult to engage by services. The patient was
referred by a community psychiatric nurse (CPN) whom was struggling to contain and
help her due to her state variability, impulsive acts of self-harm, and frequent requests for
help, only to be dissatisfied with the help then being offered.
Throughout the present study, the patient was prescribed two antidepressants
(Mitazapine and Venlafxine) and also took a tranquilliser (Zopiclone) when her sleep was
poor. She had a previous course of counselling in primary care, but reported feeling
patronized by the counsellor and dropped out. The patient dropped out of CBT offered
through the Improving Access to Psychological Therapies (IAPT) service. She was in
contactwith the communitymental health team at the time of the study andhad a 6-month
psychiatric review and infrequent home visits from a community nurse. The patient had
attended a psychoeducational group regarding BPD management which she found
helpful.
The patient was raised in a nuclear family with two female siblings. The relationship
with the father was described as poor as a child due to his violence and one of the
grandparents was particularly verbally critical. She was chronically bullied at school, was
sexually abused as a child, andwas raped aged 16 years, resulting in herwithdrawing from
the world and relationships. There was a period of heavy amphetamine and MDMA abuse
in her early twenties. Her first marriage lasted for 4 years, but was marred by violent rage
attacks on her husband. Her next relationshipwas alsomarred by her violence to her then
partner. The next significant relationship resulted in a daughter, butwas terminated after a
very violent assault on her by the partner. Physical assault was the norm in this
relationship. The patient fled and temporarily lived in a women’s refuge. The second
marriage was more harmonious, but the patient stated that she never loved her husband
and suddenly decided to leave him. The patient described a very limited life in which she
avoided the social world and distrusted people in general. She would spend her time
compulsively exercising (up to 3 hr per day) in the flat as a means of managing her mood
and the voices that she heard. When she was particularly low in mood, she reported
hearing two female voices, one of which was very derogatory and negative. The patient
would have periodic substance misuse binges. She stated that she had little idea who she
was as a person and could not articulate any personal values. She reported a sense of
personality fragmentation and quickly altering between self-states. The patient reported a
deep distrust of others and noted that she assumed that if she allowed someone to get
close to her, then theywould hurt and/or abandonher. Thepatient reported thepresence
of dissociative episodes and trance states. She gave numerous examples of exiting
dissociative episodes and finding the damage that she had done to her property. The
patient had not worked for many years due to presence of psychological symptoms. Pre-
vious employment experiences had tended to flounder because of aggressive behaviour
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towards colleagues. She described hermood as typically bleak and flat. She stated that she
hated herself and that she was disgusting.
Treatment
Treatment was delivered in the United Kingdom in a tertiary outpatient psychotherapy
service provided by the National Health Service. The therapist was a male Consultant
Clinical Psychologist and CAT psychotherapist and had clinical supervision provided by a
UKCP CAT psychotherapist. Following a screening session, the patient was allocated to
twoblocks of 24 sessions ofCAT, plus six-month follow-up. Treatment inCAT is normally
8, 16, or 24 sessions, but extended treatment contracts for BPD are possible according to
the needs of the patient (Ryle&Kerr, 2003). The treatment planwas to do specific trauma-
focusedwork in the second block of treatment after the stabilization of the first phase. The
patient had a poor response to the start of the trauma treatment and deteriorated rapidly –
therefore the second block of the CAT continued the work of the first. The rationale for
having a treatment withdrawal phase to the studywas explained to the patient as that this
period would allow her to practise the exits learnt in the first phase of therapy and also
practise the therapy coming to an end and therefore being able to process and explore
abandonment issues. Sessions were weekly and lasted for 50 min. All sessions were
attended and were conducted by the same therapist regardless of study phase. The first
three sessions were focal to assessment tasks (e.g., taking a history etc.) and so did not
contain any treatment elements and culminated in a narrative reformulation (i.e., read at
session four). The narrative reformulation made links between the past and present, and
stated the target problems and target problemprocedures (Ryle&Kellett, 2018). Thiswas
considered the end of the baseline and the start of active treatment, as is consistent with
previous CAT SCED research (Kellett, Simmonds-Buckley & Totterdell, 2016).
In terms of treatment fidelity, the hallmark components of CAT therapy are a narrative
reformulation, a sequential diagrammatic reformulation, and goodbye letters exchanged
at the termination of therapy by patient and therapist (Ryle & Kerr, 2003); in the current
case, all these distinctive features of the CAT model were present. Each component was
reviewed and appraised at clinical supervision, and sections of audio-recording from
sessions were taken to supervision. One entire 50-min audio-recorded treatment sessions
were sampled from each active phase of treatment (sessions 16 in phase 1 and session 34
of phase 2). Thesewere rated by the therapistwith the Competence in Cognitive Analytic
Therapy measure (Bennett & Parry, 2004). The CCAT contains 77 elements of therapist
competence across 10 domains of therapeutic practice. The CCAT score was 30/40 for
session 16 and 32/40 for session 34,with 20 being the cut-off for competent CAT (Bennett
& Parry, 2004).
Treatment was theoretically grounded in the sequential diagrammatic formulation
which was underpinned by CAT’s multiple self-states model (MSSM; Pollock et al., 2001)
describing the following key states: blind rage (with the reciprocal roles of abusing/
attacking to abused/shamed/weak), ’lost-world’ (with the reciprocal role of abandoning–
abandoned), ’protector’ (with the reciprocal role of protecting safe), and ’old-bagging’
(with the reciprocal role of criticizing/humiliating to humiliated/put down) and a numb
cut-off dissociated state. The states were elicited using the states description procedure
(SDP) approach (Ryle, 2007), and a self-states sequential diagrammatic reformulation was
co-produced with the patient (Ryle, Beard, & Marlowe, 1995). The ’exits’ that the patient
developed were (1) assertiveness, (2) walking away from rage, (3) stopping rescuing, (4)
allowing the daughter to grow up, (5) limiting exercise to one-hour every two days, (6)
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limiting alcohol intake, (7) being less self-critical andmore cognitively flexible, (8) trusting
self, and (9) exposure to social contact. CAT is also a therapy that actively works with
enactments in the therapeutic relationship (Ryle & Kellett, 2018). The most common
enactment was analysis of the ‘old-bagging’ state during treatment sessions and the ‘lost-
world’ state during preparation for the treatment withdrawal phase and the end of the
second active treatment phase.
Idiographic outcome measures
The seven idiographic measures were separated into three categories: emotions, self-to-
self, and other-to-self. Eachmeasurewas scored on a 10-point Likert scale from0 (not at all)
to 10 (completely). The ‘emotions’ category contained three measures: feeling
abandoned, feeling anxious, and feeling lonely. The ‘self-to-self’ category contained
two measures: hating myself and a poor sense-of-self. The ‘self-to-other’ category
contained two measures: distrusting of others and over-sensitive. Positive change was
indicated by a decrease in scores in all idiographic measures, except ‘sense-of-self’
measure, where positive change was indicated by a score increase.
Nomothetic outcome measures
The Borderline Symptom List (BSL-23; Bohus et al., 2009) assesses intenisty of BPD
symptoms over the previousweek and contains 23 items (rated 0–4). BSL-23 caseness cut-
off is a score of 2. The BSL-23 has good internal (a = .96) and test–retest (r = .82,
p < .001) reliability. The BSL-23 was the primary nomothetic outcome measure for the
study. Beck Depression Inventory-II (BDIII; Beck, Steer, & Brown, 1995); this measure
contains 21 items that measure the intensity of depressive symptom (Beck, Steer, Ball &
Ranieri, 1996),with a clinical cut-off score of 17. BDI-II scores are coded as 0–13=minimal
depression, 14–19 =mild depression, 20–28 =moderate depression, and 29–63 = severe
depression. Brief Symptom Inventory (BSI; Derogatis, 1993); the BSI (53 items) is a valid
and reliable measure of psychological distress (Derogatis, 1993) consisting of three
subscales; the global severity index (GSI) is the most commonly reported. A raw score
>.78 on the BSI-GSI relates to the patient reaching ‘caseness’ on themeasure. Inventory of
Interpersonal Problems-32 (IIP-32; Barkham, Hardy, & Startup, 1996); this tool measures
interpersonal problems and is a shortened version of the IIP-126 (Barkham et al., 1996).
The IIP-32 has four scales relating to interpersonal functioning and four scales identifying
problematic and dysfunctional interpersonal strategies (Hughes & Barkham, 2005).
Session impact measure
The Session Impact Scale reliably measures the experienced personal impacts of
psychotherapy sessions in termsof the key features of the session (Elliott&Wexler, 1994).
The 16 SIS items form three factors: the task focus of the session, the quality of the
therapeutic relationship, and whether anything hindering occurred. Item 17 is used to
provide qualitative data on any ‘other important impacts’ that occurred during the
session.
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Table 1. Summary of the function of the tests used in the analyses
Ideographic or nomothetic test Function of the test
Ideographic; analysis of covariance (ANCOVA) Toexamine the phase differences in themean values of the ideographicmeasures that are related to the effect
of the CAT intervention, whilst taking into account the influence of the uncontrolled independent variables
Ideographic; bonferroni correction A multiple-comparison correction was used when several statistical tests are being performed
simultaneously, that is employed in order to avoid producing spurious positive results
Ideographic; percentage exceeding the median The analysis of the effectiveness of theCAT intervention phase data that is contingent on the overlapwith the
median data point within the baseline phase and is based on the assumption that if the CAT intervention (B
phases) was effective, ideographic outcome data will predominately exist on the therapeutic side of the
median; if the CAT intervention was ineffective, data points during the treatment B phases would vacillate
above and below the baseline median
Ideographic; non-overlap of pairs Calculation of non-overlap between the baseline and successive CAT intervention B phases; this test
identifies the highest data point in baseline to determine the percentage of data points during CAT
intervention B phases that exceeded this level and therefore assesses effectiveness
Ideographic; Tau-U Tau-U statistics assessed change between phases whilst accounting for potential baseline trend. Tau-U
analyses included (1) analysis of baseline trend, (2) difference between phases (sA vs. B) which essentially
emulates a Mann–Whitney test, and 3) s(A–B)-Atrend which compares phases whilst adjusting for baseline
trend. It is recommended that if baseline trend is not significant then s(A–B)-Atrend is not indicated and that
s
A vs. B should be used (Bossart, Laird, & Armstrong, 2018)
Nomothetic; reliable change To differentiate change in a nomothetic outcome that is statistically significant from change that may have
occurred due to measurement error
Nomothetic; reliable and clinically significant change To identify when the change is both reliable (see above) and also when the scores have shifted from in the
clinical range to the community range
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Table 2. Mean (SD) of ideographic measures over the study phases
Ideographic daily
measure (1–10) scale
Baseline
mean (SD)
CAT first treatment
phase mean (SD)
Treatment
withdrawal (SD)
CAT second treatment
phase mean (SD) Follow-up (SD) F value
Feeling abandoned 8.50 (0.75) 8.09 (1.02) 8.17 (0.99) 7.60 (1.39) 9.04 (6.06) 4.14**
Feeling anxious 8.73 (1.07) 8.16 (1.31) 8.09 (1.06) 7.92 (1.65) 8.86 (1.12) 3.79**
Feeling lonely 9.15 (0.85) 8.44 (1.24) 7.44 (0.88) 7.97 (1.53) 8.58 (1.73) 3.91**
Self-hate 9.41 (0.81) 8.70 (1.57) 6.18 (1.49) 6.34 (2.21) 8.32 (1.14) 11.24**
Sense-of-self 0.83 (0.97) 2.12 (1.37) 2.87 (0.94) 3.06 (2.01) 1.61 (0.94) 6.92**
Distrusting of others 8.98 (0.61) 9.24 (0.51) 8.82 (0.51) 8.92 (0.91) 9.57 (0.50) 6.33**
Feeling over-sensitive 9.56 (0.64) 9.05 (0.88) 8.56 (0.67) 8.84 (0.92) 9.49 (0.77) 4.90**
Note. **p < .001.
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Analysis strategy
Table 1 provides a description of the tests used for the idiographic and nomothetic data
and definitions of the purpose of the tests. To adjust for any autocorrelation in the time-
series ideographic measures, then partial autocorrelation function (PACF) plots were
calculated in order to show which lag in each ideographic measure was appropriate for
subsequent use in the ANCOVA analysis. Autocorrelation is the non-independence of
Figure 1. Time-series plots for ideographic emotion measures including baseline median (across phase
horizontal dotted red line) and phase trend lines (within phase dotted red lines).
Figure 2. Time-series plots for self-to-self ideographics including baseline median (across phase
horizontal dotted red line) and phase trend lines (within phase dotted red lines).
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sequential observations in a time series and also known as serial dependence (Borckardt,
Nash, Murphy, Moore, Shaw, & O’Neil, 2008). Autocorrelation in time-series data biases
the standard errors and so potentially positively distorts subsequent results (Drucker,
2003), and so removing the autocorrelation ensured the reliability of the standard errors
used in the ANCOVA. The PACF plots are displayed in the Figure S1. First-order lags were
appropriate to be applied for all idiographic measures, except the feeling abandoned
measure, where a second-order lag was most appropriate. ANCOVA then tested for any
differences between the phases of the study, and the lags were used as covariates (Kellett
& Totterdell, 2013). Despite the ideographic measures violating assumptions of
homogeneity of variance, the analyses were still performed due to the robustness of
ANCOVA (Schmider, Ziegler, Danay, Beyer, & B€uhner, 2010). The ANCOVA had a single
factor (study phase) and five levels (A1/B1/A2/B2 and FU), and a bonferroni correctionwas
applied. Partial g2 was used to calculate the effect sizes from the ANCOVAs and was
interpreted as follows: 0.01 = small effect, 0.06 = medium effect, and 0.14 = a large
effect. Analysis of non-overlap statistics (percentage exceeding themedian; PEM and non-
overlap of all pairs; NAP) was also performed in order to assess the degree of change
between phases on idiographic measures. Time-series graphs (with trend lines fitted and
baseline medians) were created for each idiographic measure and weekly SIS score to
display change by phase of study. Changes in session impact were assessed via ANOVA of
SIS subscale scores and also non-overlap statistics. Qualitative data from item 17 of each
SIS score for 44of 48 sessions that this itemwas completedwere coded as either a positive,
mixed, or negative impact (see Appendix S1 for the qualitative SIS comments), and these
ratings were second-rated to assess inter-rater reliability; the percentage of agreement
between the raters was 86.36%. Nomothetic outcomes were analysed using the reliable
change index for each measure (RCI; Jacobson & Truax, 1991) and also reliable and
clinically significant change (RCSC, Jacobson & Truax, 1991).
Figure 3. Time-series plots for self-to-other ideographics including baseline median (across phase
horizontal dotted red line) and phase trend lines (within phase dotted red lines).
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Results
Results are presented in three sections: idiographic outcomes (according to emotions,
self-to-self, and self-to-other), nomothetic outcomes, and then session impact scores. The
general patterns across the ideographic outcomes were that the first treatment phase
created reductions in BPD ideographic outcomes, but therewere patterns of deterioration
evident over the follow-up period. Table 2 provides a summary of means (SD) on the
idiographic measures reported by study phase, whilst Table 3 contains the non-overlap
and TAU-U results comparing the phases. Where Tau baseline trend for an ideographic
measure was significant, Tau-U statistics are reported, and where baselines trends were
stable, TauA-B is reported. Figures 1–3 present the time-series graphs for each ideographic
measure.
Idiographic BPD outcomes; emotions
Visually, all the emotion measures showed an improvement during the first treatment
phase and withdrawal, there was a variable response to the second treatment phase, and
all showed deterioration over the follow-up (see Figure 1). Therewas a significant effect of
the phase for feeling abandoned with a small effect size; F(4, 690) = 4.14, p < .05,
g
2
= .02. The non-overlap results indicated that CAT was ineffective (PEM = 61.41%,
NAP = 59.47) when baseline was compared with all subsequent phases pooled together;
however, this effect was statistically significant when analysed using Taua-b (s = .184,
p = <.05). Taua–b was not significant when comparing baseline and follow-up alone.
Therewas a significant effect of the phase for feeling anxious, with a small effect size; F(4,
691) = 3.79, p < .05, g2 = .02. CAT was ineffective on anxiety when baseline was
compared with all other phases combined (PEM = 58.50%; NAP = 58.86). Tau(a–b)-trend
was significant between baseline and the first treatment phase (s = .248, p = <.05), and
Figure 4. Plots for SIS subscales including phase trend lines (within phase dotted red lines) across
baseline and first and second CAT treatment phases.
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Table 3. Non-overlap results comparing the ideographic measures between phases
Daily measure
Baseline vs. first CAT treatment phase (CAT 1)
First CAT
treatment phase
(CAT 1) vs. follow-
up
First CAT treatment
phase (CAT 1) vs.
withdrawal
Baseline + withdrawal
vs. CAT 1 + 2
Baseline trend sA vs. B s-U NAP PEM NAP PEM NAP PEM NAP PEM
Abandoned .002 .224* .201* 61.48 67.82 69.33 54.91 59.29 58.89 59.09 34.77
Anxious .278* .244* .248* 62.21 60.34 65.75 60.34 65.19 65.77 53.56 36.39
Lonely .377* .304* .307* 65.18 55.17 62.51 62.64 89.99a 88.29a 42.10 31.00
Self-hate .288* .339* .334* 66.97 68.39 77.82a 76.44a 96.75b 100b 43.26 27.22
Sense-of-self .326* .574* .548* 78.69a 85.06a 74.30a 81.03a 92.14b 99.1b 52.12 24.53
Distrusting .062 .211* .195* 39.47 4.45 70.94a 56.90 56.24 15.32 40.95 16.98
Over-sensitive .0340* .340* .281* 67.44 66.66 69.79 63.22 84.74a 97.3b 45.99 31.35
Baseline vs. second CAT
treatment phase (CAT 2) Baseline vs. follow-up Baseline vs. CAT 1, withdrawal, CAT2 and follow-up
NAP PEM sA vs. B s-U NAP PEM sA vs. B s-U NAP PEM
Abandoned 69.22 71.79a .068 .061 46.50 45.09 .184* .179* 59.47 61.41 (38.41)
Anxious 63.35 69.23 .073 .037 46.36 39.88 .177 .180* 58.86 58.5
Lonely 71.81 57.44 .061 .090 53.06 37.57 .364* .363* 68.18 56.81
Self-hate 91.86 94.87b .540* .514* 77.02a 82.66a .641* .631* 82.11a 85.45a
Sense-of-self 87.15 96.41b .483* .467* 74.14a 88.44a .646* .637* 82.30a 91.73b
Distrusting 50.68 28.72 .486* .442* 25.71 0 .641* .631* 82.11a 85.52a
Over-sensitive 72.40 70.26a .034 .006 51.73 36.00 .345* .328* 78.69a 65.24
Note. aIndicates highly effective treatment. bIndicates moderately effective treatment. *Significant at p = .005.
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between baseline and all other phases was (s = .180, p = <.05); however, Tau(a–b)-trend
was not significantwhen comparing baseline and follow-up. Therewas a significant effect
of phase on loneliness, with a small effect size; F(4, 691) = 3.91, p < .05, g2 = .02. Non-
overlap results indicated that CAT was ineffective for loneliness (PEM = 56.81%;
NAP = 68.15%). Tau(a–b)-trend statistics were significant when comparing the loneliness
baseline and the first CAT treatment phase (s = .307, p = <.05), and between baseline
and all other phases (s = .363, p = <.05). However, the Tau(a–b)-trendwas not significant
when comparing baseline loneliness to follow-up loneliness.
Idiographic BPD outcomes; self-to-self
Visually, both self-to-self measures responded to the first treatment phase and also the
withdrawal, but deteriorated over the follow-up (see Figure 2). There was a significant
effect of phase on self-hate with a medium effect size; F(4, 689) = 11.24, p < .001,
g
2
= .06. Non-overlap results indexed that CAT was moderately effective for self-hate
(PEM = 85.45%; NAP = 82.11%). Tau(a–b)-trend statisticswere significantwhen comparing
the self-hate baseline and the first treatment phase of CAT (s = .344, p = <.05), baseline
and all other phases (s = .514, p = <.05), and baseline with follow-up (s = .631,
p = <.05). There was a significant effect of phase on sense-of-self with a medium effect
size; F(4, 691) = 6.92, p < .001, g2 = .04. PEM results CAT to be a highly effective
treatment for sense-of-self (PEM = 91.73%; NAP = 82.30%). Tau(a–b)-trend statistics were
significant when comparing sense-of-self baseline and B1 (s = .548, p = <.05), baseline
and all other phases (s = .637, p = <.05), and baseline with follow-up (s = .467,
p = <.05).
Idiographic BPD outcomes; self-to-other
Visually, the interpersonal over-sensitivity measure was stable during the first treatment
phase and withdrawal, improved during the second phase, and deteriorated over the
follow-up (see Figure 3). The distrust of others ideographicmeasure appeared fairly stable
across all the phases (see Figure 3). There was a significant effect on interpersonal
sensitivity, with a small effect size; F(4, 687) = 4.90, p < .001, g2 = .03. Non-overlap
results indicated that CAT was ineffective for over-sensitivity (PEM = 65.08%;
NAP = 78.69%). Tau(a–b)-trend statistics were significant when comparing over-sensitive
baseline and B1 (s = .281, p = <.05), and between baseline and all other phases was
(s = .328, p = <.05); however, Tau(a–b)-trend was not significant when comparing
baseline and follow-up. There was a significant effect on distrusting others, with a small
effect size; F(4, 691) = 6.33, p < .001, g2 = .04. Non-overlap results indicated an
ineffective treatment for the ability to trust others (PEM = 85.51%;NAP = 81.11%). Tau(a–
b) statistics were significant when comparing distrusting baseline and B1 (s = .211,
p = <.05), baseline and all other phases (s = .486,p = <.05), and baseline and follow-up
(s = .641, p = <.05).
Nomothetic outcomes
Table 4 summarizes nomothetic outcomes. The BSL-32 showed reliable (but not clinical)
change only from baseline to the end of the first treatment phase (RCI = 2.11, p < .05).
On the BDI-II measure, reliable (but not clinical) change occurred only from the baseline
phase to the end of the first treatment phase (RCI = 3.55, p < .05). The BSI-GSI measure
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Table 4. Nomothetic measure outcome (with normative comparisons)
Measure
Caseness
cut-off Baseline CAT 1
Treatment
withdrawal CAT 2
Follow-
up
Clinical
mean (SD)
Community
mean (SD) RCI-1 RCI-2
RCI-
3 RCI-4
Reliable
and
Clinically
significant
change
from
baseline to
end of
follow-up?
BSL-32 2.00 3.56 2.95 2.78 2.56 2.03 2 (0.76) 0.4 (0.22) 2.11* 0.59 0.76 1.84 No
BDI-II 17.00 51 31 28 25 27 20.44
(13.28)
10.04 (8.23) 3.55* 0.53 0.53 0.35 No
BSI-GSI 63.00 3.35
(78.00)
2.65
(69.00)
2.24
(63.00)
1.98
(61.00)
2.03
(61.00)
1.32
(0.72)
0.30
(0.31)
2.17* 1.27 0.81 0.16 Yes
IIP-32 1.39 1.71 2.12 2.34 1.65 1.71 1.51 0.98 1.14 0.61 1.92 0.17 No
Note. RCI-1 is from the baseline to end of the first CAT treatment phase; RCI-2 is from the end of the first CAT treatment phase to the end of the treatment
withdrawal phase; RCI-3 is from the end of the treatment withdrawal phase to the end of the second CAT treatment phase; RCI-4 is from the end of second CAT
treatment phase to the end of follow-up. Scores in bold indicate where a score is in the clinical caseness range at that time.
*Indicates reliable change. Clinical and community norms were taken from the following papers: Beck Steer Ball and Ranieri (1996) for BDI-II, Derogatis (1993) for
BSI-GSI, Barkham et al. (1996) for IIP-32, and Bohus et al. (2009) for BSL-32.
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Table 5. Session impact results
SIS subscale
Means (SD)
F-value
PEM (NAP)
Baseline
M (SD) CAT 1 M (SD) CAT 2 M (SD)
Baseline
sessions vs.
CAT 1
Baseline
sessions vs.
CAT 2
Baseline
vs. all CAT
treatment
sessions
Task 10.33 (0.58) 18.86 (3.79) 19.21 (3.27) 9.06* 95.24** (95.24**) 100 (100) 97.78 (97.78)
Relationship 18.00 (2.65) 20.76 (3.66) 20.25 (3.31) 0.86 66.67 (76.191) 62.50 (72.22) 64.44 (74.07)
Hindering 8.33 (2.31) 9.43 (2.27) 10.04 (2.51) 0.86 76.19 (65.08) 91.67 (72.22) 84.44 (68.89)
Item 17: Other important impacts
Negative impact N (%) 1 (33%) 4 (19.05%) 6 (26.09%)
Mixed impact N (%) 2 (66%) 3 (14.29%) 5 (21.74%)
Positive impact N (%) 0 12 (57.14%) 9 (39.13%)
Note. *Significant at p = .005; **Indicates highly effective treatment.
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showed reliable (RCI = 2.17, p < .05) and clinically significant change from the baseline
phase to the end of the first treatment phase. The BSI-GSI was in the non-caeness range at
the end of the second phase of CAT treatment and at follow-up. On the IIP-32 measure,
therewas no reliable change across any phase of the study and also no clinically significant
change.
Session impact outcomes
Table 5 reports the session impact scores on the SIS subscales and the qualitative item
(i.e., item 17). Plots of session impact sub-domains can be seen in Figure 4. The task focus
in the sessions significantly increased over the phases of the study, F(2, 45) = 9.06,
p = <.001. There were high levels of non-overlap and hence impact when comparing
baseline sessions with sessions during the first CAT treatment phase (PEM = 95.24%;
NAP = 95.24%), baseline and the second CAT treatment phase (PEM = 100%;
NAP = 100%), and baseline and combined CAT treatment phases (PEM = 97.78%;
NAP = 97.78%). There was no significant change on the relationship scale, F(2,
45) = 0.86, p = .43 nor the hindering scale, F(2, 45) = 0.86, p = .43) over time. During
the baseline phase sessions, the most common impact was mixed (2/3); during the first
treatment phase; the most common session impact was positive (12/19); and during the
second treatment phase, the most common session impact again was positive (9/24).
Discussion
The purpose of this study was to evaluate the effectiveness of CAT for a patient with BPD
in a previously unused A/B/A/B design, and in particular to explore whether a treatment
withdrawal phase could be matched to helping the patient better prepare for the actual
end of the therapy, as fear of abandonment is a core feature of BPD (Palihawadana et al.,
2019). The length of the time series achieved is unique in the BPD SCED outcome
evidence base regardless of treatment modality. The fidelity and competency evidence
provided reassurance that CATwas delivered, the session impact scoreswere consistently
high, and qualitative session impact themes tended to be positive. Four of the seven
ideographic outcome measures had unstable baselines (i.e., feeling abandoned, self-hate,
poor sense-of-self, and being over-sensitive), but it is worth noting that instability tended
to reflect that deterioration in these measures was occurring during the baseline. In a
disorder like BPD where variability is actually part of the clinical picture (Ryle & Kerr,
2003), then it is perhaps naive to expect stability during SCED baselines. The principle
clinical concern in the current study was the observed deterioration from second
treatment phase to follow-up, considering amain challengewith BPD patients is reducing
over-dependence on mental health services (Nehls, 2000). Whilst consistent efforts were
made to prepare the participant for the termination of therapy, the deterioration evident
in the time-series data raises doubts aboutwhether CAT (in this case) adequately prepared
the participant. The participant made particularly good use of the treatment withdrawal
phase and was not affected by any negative life events during this period. It was the
impression of the therapist that theparticipant appeared to understand and appreciate the
efforts beingmade to help her acclimatize to abandonment issues. The follow-up sessions
were particularly marked by the participant struggling with their mood and some
evidence of returning to habitual roles and patterns due to the series of negative life
events.
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Overall, the results suggest a partially effective intervention and previous clinical trial
and cohort studies have found CAT to be effective in alleviating BPD symptoms (Chanen
et al., 2008; Kellett et al., 2013). The partially effective outcome and also the good
attendance of the participant need to be seen in the context of the previous poor therapy
outcomes and rejection of previous psychological interventions. Where change occurred
in the idiographic BPDmeasures, then it appears that the self-to-self measures were more
responsive to treatment than the emotions or self-to-other measures. CAT appeared
moderately effective in terms of reducing self-hate. This is an important reduction
considering that suicidality and punishing self-injury among BPD patients often stem from
feelings of self-hatred (Brown, Comtois & Linehan, 2002). The non-overlap results also
suggested that CAT was a highly effective treatment for improving the ‘sense-of-self’
ideographic measure, and this is in line with previous evidence that CAT assists BPD
patients in personality integration efforts (Kellett et al., 2013). The evidence from this
study is that that such personality integration work is both a lengthy and time-consuming
effort, andperhaps BPDpatientsmake a startwith this goal during therapy and then spend
a great length of time subsequent to the therapy continuing and completing this work.
The nomothetic outcomes of the study would mirror the ideographic outcomes in
suggesting a partially effective intervention. In 3/4 nomothetic measures (BSL-32, BDI-II,
and IIP-32), reliable changewas seen frombaseline to first treatment phase, but no further
reliable change occurred. This evidence would be consistent with the ‘dose–effect’
relationship in psychotherapy, that the course of improvement over sessional time
follows a negatively accelerating pattern of change, irrespective of actual eventual
duration of the intervention (Robinson,Delgadillo,&Kellett, 2019; Rubel, Lutz,& Schulte,
2015). Just one nomothetic measure (BSI-GSI) recorded a realibale and clinically
significant change frombaseline assessment to the end of follow-up. It isworth noting that
the BSL-32 was just above the cut-off score by the end of the follow-up. In terms of
outcome, the ‘task’ subscale on the SIS significantly increased from baseline to treatment
phases, indicating that treatment sessions were more task-focused. This increase in task
focus is a feature of the phase change of CAT from reformulation to more active
recognition/revision and has been previously illustrated (Spence, Kellett, Totterdell &
Parry, 2019). Despite no significant change being recorded in the ‘relationship’ SIS
subscale, scores were consistently high, indicating that throughout the therapy the
patient felt positively towards the therapist and the course of therapy.
There are multiple possible explanations for the patient’s mixed outcome. BPD
patients commonly relapse and deteriorate after intervention (Jerschke,Meixner, Richter,
& Bohus, 1998; Mohr, 1995) and individual differences in condition severity, chronicity,
comorbidity with other conditions, and history of contact with mental health services all
moderate how patients respond to the termination of interventions (Davidson & Scott,
2009). The participant in the current study had been in the mental health service for
18 years prior to the study commencing, had been non-responsive to previous
psychological interventions, and was extremely socially isolated by choice. It has been
previously argued that a reduction in distress during the early stages of CAT is crucial in
enabling hope and before more complex state integration work is possible – but this does
not seem to have been the case here (Kellett et al., 2013). Given research on the
effectiveness of CAT on BPD patients showing sub-syndromal or first-presentation
symptoms (Chanen et al., 2008), the patient’s poor outcomes may be a result of late
intervention (with a history of previously failed interventions), so illustrating the
importance of addressing BPD early in its presentation.
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The patient’s attendance suggests the acceptability of CAT for BPD and also supports
previous research showingCAT’s consistently lowdrop-out rate (Calvert &Kellett, 2014).
Amethodological strength of the SCEDwas the introduction of a treatment removal phase
and the length of the follow-up, with the daily idiographic measures indexing change on
an intricate micro level. The collection of such an extensive time series suggests that the
close alignment of the patient and the therapist on the design of the measures made them
representative of the central goals of the work, and therefore, the measures were non-
burdensome (Kellett & Beail, 1997). An A/B/A/B design possesses advantages over usual
bi-phasic A/B designs (Kazdin, 1978), as repeated change in both treatment phases
compared to non-treatment phases better tests that treatment has affected change,
reducing the possibility of attributing change to other factors (passage of time, regression
to the mean etc.; Rizvi & Nock, 2008). However, A/B/A/B designs are typically
implemented with purely behavioural interventions and they are therefore not immune
to ‘bleed-over’ in learning across the phases during psychotherapy (McMillan & Morley,
2010). Indeed, that was the aim of the intervention, to help the participant more
effectively tolerate abandonment feelings through carryover of learning. Ethical dilemmas
are also apparent when using treatment withdrawal phases for severe cases of BPDwhen
the withdrawal of the treatment might dangerously increase self-destructive behaviours
(Hersen & Barlow, 1976).
In terms of other limitations, the generalizability of the study to other BPD patients is
open to question. The data were collected via self-report, which limits confidence in the
reliability of the results, raising issues of social desirability bias (Arnold & Feldman, 1981;
Nicklas, Dunbar & Wild, 2010). Therefore, some other informant data would have been
useful (Kellett & Totterdell, 2013), but the participant’s social isolation and fear of contact
with others made this impossible. Additional nomothetic outcome measures may have
been appropriate to use, for example, the Personality Structure Questionnaire (PSQ;
Pollock, Broadbent, Clarke, Dorrian & Ryle, 2001) to assess change in state-shifting and
the Scale for Suicide Ideation (e.g., the SSI; Beck, Kovacs & Weissman, 1979) to more
closely capture change in risk issues.Wider sampling of competency across the treatment
phases would have been useful also. The study methodology could have been improved
through the addition of idiographic control and also generalization measures (Krasny-
Pacini & Evans, 2018). But, a potential criticism is also the wide range of outcomes
assessed and the associated risk of false-positive findings. This criticism is defended by the
use of bonferroni corrections in the ANCOVA analysis of the ideographic outcomes.
Finally, the benefits of the withdrawal design were research related, and so the repeat of
such a designmaynot be aswell tolerated by other BPDpatients. It isworth noting that the
treatment withdrawal phase was agreed at the outset, and therefore, treatment
withdrawal was not ‘sprung’ on the patient, but rather diligently planned for. Future
SCEDswith BPDpatientsmay seek to utilize cross-over designs, as they appear to have less
ethical dilemmas, due to random allocation to two different, but active, treatments (Jones
& Kenward, 2014). For example, rather than withdrawing CAT, a BPD patient could be
randomly allocated to CAT followed by CBT (or vice versa).
To conclude, this innovative and methodologically unique study has indexed a mixed
outcome of CAT for a patient with BPD whomwas treated in routine practice. The study
has used a rigorous SCED methodology which heightens the reliability and internal
validity of the study, and confidence in the conclusions drawn that the intervention was
partially effective. The study’s single-case design is the main challenge to the general-
izability of the findings. As abandonment fears are central to BPD, the opportunity to use
withdrawal designs is unique, but this needs to be carefully, clinically, and ethically
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consideredprior to implementation. This researchnevertheless supports CATs continued
use with BPD and also highlights the flexibility and rigour of the SCED method.
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